This smart signal does three jobs at once
GLP-1 medications target this root cause effectively
As research in this field continues to evolve, ongoing and future CVOTs will likely expand our knowledge of the cardiovascular benefits of GLP-1 receptor agonists, ultimately improving the care and outcomes of individuals with T2D and CVD
This information may help explain why certain GLP-1 formulations or doses work better for some patients than others, though genetic data should complement, not replace, clinical evaluation
The uncomfortable answer is that a consumer patch can reference a famous drug without containing it and without meeting the safety and quality standards required for prescription therapy
Curcumin and EGCG therapy combined improved axonal sprouting, reduced glial scar formation, and altered cytokine levels, but their synergistic effect was less noticeable